Impact on Opioid Use of Bundling Medication-assisted Treatment With mHealth (Bundling)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02712034|
Recruitment Status : Recruiting
First Posted : March 17, 2016
Last Update Posted : October 16, 2017
|Condition or disease||Intervention/treatment||Phase|
|Opioid Use Disorder||Behavioral: MAT + A-CHESS Other: MAT||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||440 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Investigator, Outcomes Assessor)|
|Primary Purpose:||Supportive Care|
|Official Title:||Impact on Opioid Use of Bundling Medication-assisted Treatment With mHealth|
|Study Start Date :||April 2016|
|Estimated Primary Completion Date :||April 2020|
|Estimated Study Completion Date :||August 2020|
Placebo Comparator: Medication-assisted treatment (MAT)
Patients will receive standard medication-assisted treatment (MAT) as prescribed by their health care provider.
Patients will receive treatment consisting of a recovery plan, appropriate pharmacology, routine urine screens, and regularly scheduled behavioral interventions, such as monthly group counseling sessions or sessions with a recovery coach. "Appropriate pharmacology" may include methadone; naltrexone; buprenorphine; and in the case of overdose, naloxone; and other medications and combinations of medications as part of the patient's standard clinical care.
Experimental: MAT + A-CHESS
Patients in the MAT + A-CHESS arm will receive MAT as described plus the A-CHESS recovery support system via a smartphone.
Behavioral: MAT + A-CHESS
Subjects randomized to MAT + A-CHESS will receive MAT plus the A-CHESS recovery support system which provides:
- Opioid use [ Time Frame: 24 months ]Detect the difference in illicit opioid use between patients who have MAT + A-CHESS vs. MAT alone.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02712034
|Contact: Gina M Landucci, BSfirstname.lastname@example.org|
|United States, Wisconsin|
|Access Community Health Centers||Recruiting|
|Madison, Wisconsin, United States, 53713|
|Principal Investigator:||David H Gustafson, PhD||UW Madison|